B ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1
Clinical trials for B ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1 explained in plain language.
Never miss a new study
Get alerted when new B ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1 trials appear
Sign up with your email to follow new studies for B ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver shield: nutrient may prevent chemo side effect in young leukemia patients
Disease control OngoingThis study tests whether adding levocarnitine, a natural nutrient, to standard chemotherapy can prevent severe liver damage in teens and young adults (ages 15-39) with leukemia or lymphoma. Liver toxicity from the chemotherapy drug asparaginase often forces treatment delays, whic…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 17, 2026 03:28 UTC
-
Promising new combo therapy for leukemia patients shows potential
Disease control OngoingThis study looks at whether adding a drug called blinatumomab to the usual treatment (steroids, a targeted pill, and chemotherapy) helps adults with a specific type of leukemia (BCR-ABL-positive ALL) live longer. About 348 newly diagnosed patients aged 18 to 75 are taking part. T…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Promising combo targets leukemia in older patients
Disease control OngoingThis study tests two drug combinations for adults aged 65 and older with acute lymphoblastic leukemia (ALL). One group gets blinatumomab plus standard chemotherapy; the other gets blinatumomab, dasatinib, and prednisone. The goal is to see if these combos help control the cancer …
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New drug combo shows promise against tough leukemia
Disease control OngoingThis study tested a powerful chemotherapy regimen (Hyper-CVAD) combined with the targeted drug ponatinib in 88 adults with a specific, aggressive leukemia (Philadelphia chromosome-positive ALL). The goal was to see if this combination could improve how long patients stayed cancer…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:44 UTC
-
New cocktail of drugs shows promise against tough leukemia
Disease control OngoingThis early-phase study tests a combination of drugs, including venetoclax, for adults with a specific type of leukemia (Ph+ ALL) that is either newly diagnosed or has returned. The goal is to find the safest dose and see how well the treatment works. About 20 participants will re…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA WITH T(9;22)(Q34.1;Q11.2); BCR-ABL1
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 11, 2026 20:41 UTC